Breaking News
Get 45% Off 0
🎯 Trump Tariffs Hit Markets: Here's What Smart Investors Should Consider
Read now

Zacks Investment Research Zacks Investment Research

Zacks Investment Research's Opinion & Analysis.
Featured here: a complete archive of all posts and research produced by Zacks Investment Research, including current material.
Buy Nike and FedEx Stock Before Earnings as Long-Term Holds? By Zacks Investment Research - Jun 22, 2021

On today’s episode of Full Court Finance at Zacks we take a look at Nike (NYSE:NKE) NKE and FedEx FDX ahead of their upcoming quarterly earnings releases on Thursday, June 24 to see if ether...

Earnings Estimates Moving Higher for Hess (HES): Time to Buy? By Zacks Investment Research - Jun 22, 2021

Investors might want to bet on Hess (HES), as earnings estimates for this company have been showing solid improvement lately. The stock has already gained solid short-term price momentum, and this...

5 Stocks Flying High Following Recent Upgrade by Analysts By Zacks Investment Research - Jun 21, 2021 5

With the second-quarter 2021 earnings season in the offing, investors will look to include a winning basket of stocks in their respective portfolios, which have the potential to surpass earnings...

Select Medical's (SEM) Growth Plans to Extend US Footprint By Zacks Investment Research - Jun 21, 2021

Select Medical (NYSE:SEM) Holdings Corporation SEM recently undertook a wide array of measures, primarily acquisitions and joint ventures (JVs) with renowned healthcare systems, to strengthen its...

Dow Soars Nearly 600 Points as Stocks Stage Big Comeback By Zacks Investment Research - Jun 21, 2021

The major indices began the week with a sharp rally that recovered Friday’s losses. The Dow was especially impressive by soaring nearly 600 points on Monday as the market calmed down over the...

Here's Why You Should Hold Onto Celanese (CE) Stock for Now By Zacks Investment Research - Jun 21, 2021

Celanese (NYSE:CE) Corporation CE is expected to benefit from its productivity measures, investments in organic projects and strategic acquisitions amid certain headwinds including raw material cost...

2 Stocks to Buy Now Before Earnings for Big Growth Upside By Zacks Investment Research - Jun 21, 2021

Second quarter earnings season unofficially kicks off in mid-July with the big banks such as JPMorgan JPM. But financial results are almost always rolling out, including quarterly reports from Nike...

Bristol Myers' (BMY) Onureg Gets European Commission Approval By Zacks Investment Research - Jun 21, 2021

Bristol Myers (NYSE:BMY) Squibb BMY announced that the European Commission (EC) has granted full Marketing Authorization to Onureg (azacitidine tablets).Onureg is authorized as a maintenance therapy...

Alerus (ALRS) Moves 5.4% Higher: Will This Strength Last? By Zacks Investment Research - Jun 21, 2021

Alerus (ALRS) shares ended the last trading session 5.4% higher at $33.30. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This...

Continue with Apple
Continue with Google
or
Sign up with Email